NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

That's not what he asked.

Disclosure Requirements
Such transactions are governed by "related party transaction" rules, which require full disclosure of the CEO's interest and control over both entities in regulatory filings (such as those with the SEC for public companies) if the value involved exceeds certain thresholds—typically transactions exceeding $120,000 must be disclosed.?

The disclosure must identify the related person, detail the relationship, quantify the transaction, describe the terms, and clarify the material interest held by the CEO.?

These disclosures appear in documents such as proxy statements, annual reports, or registration statements and cover the previous fiscal year or up to three years for registration statements.?

Board and Shareholder Approval
Because of the conflict of interest, the board must be proactive in reviewing and approving the transaction, often requiring approval by disinterested directors or even a shareholder vote, especially if the transaction is material.?

Corporate governance dictates that the CEO should recuse themselves from voting or decision-making related to the acquisition due to their dual interest.?